About Rapid Diagnostics
Rapid diagnostic tests are diagnostic assays designed for low-resource settings that provide faster results. These can be carried out either at a patient's bedside or in a clinical setting. These devices are simple to operate and read, have a low cost, and are specific, sensitive, and stable at extreme temperatures. They also provide quick results. Rapid diagnostics is the fastest-growing segment in in vitro diagnostics (IVD). Rapid diagnostic tests include agglutination, lateral flow, flow through, solid phase, and nucleic-acid amplification tests. Diagnostic devices are used to detect and measure blood glucose and coagulation levels, cardiac biomarkers, infectious diseases, hemoglobin concentration, five-part differential blood count, and pregnancy and fertility status. These tests can be used at patient's bedside, and in physician's clinics, ICUs, operating rooms, emergency rooms, and inpatient wards. The healthcare professional attending to the patient obtains the specimen, performs an analysis, and records the result.
Technavio’s analysts forecast the global rapid diagnostics market to grow at a CAGR of 7.27% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global rapid diagnostics market for 2016-2020. To calculate the market size, revenue generated from the sales of rapid diagnostics products, including over-the-counter (OTC) rapid diagnostics tests (self-testing kits, glucose meters, and strips) and professional rapid diagnostics tests (test kits, handheld devices, and small analyser) have been considered.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Rapid Diagnostics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Alere Inc.
• Beckman Coulter Inc.
• Abbott Laboratories
• Roche Diagnostics
• Siemens Healthcare
Other prominent vendors
• Abaxis
• Accriva Diagnostics
• ACON Laboratories
• A. Menarini Diagnostics
• Bayer HealthCare
• BD
• Bio-AMD
• Bio-Rad Laboratories
• Cepheid
• Chembio Diagnostic Systems
• Clarity Diagnostics
• DiagCor Bioscience
• Diasorin
• Eiken Chemical
• GlySens
• Helena Laboratories
• Hemosure
• Hologic
• Humor Diagnostica
• LifeScan
• Meridian Life Sciences
• Nipro Diagnostics
• Oasis Diagnostics
• OPKO Health
• OraSure Technologies
• Quidel
• Randox Laboratories
• Sysmex
• Trinity Biotech
• Trivitron Healthcare
• URIT
Market driver
• Increase in incidence of chronic and infectious diseases
• For a full, detailed list, view our report
Market challenge
• Pricing pressures
• For a full, detailed list, view our report
Market trend
• Use of digital platforms in rapid diagnostics
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: Market segmentation by application
• Global rapid diagnostics market by application
• Blood glucose rapid diagnostics
• Cardiometabolic rapid diagnostics
• Infectious disease rapid diagnostics
• Pregnancy and fertility rapid diagnostics
• Toxicology rapid diagnostics
• Fecal occult blood rapid diagnostics
• Coagulation rapid diagnostics
PART 07: Market segmentation by product
• OTC rapid diagnostics test
• Professional rapid diagnostics test
PART 08: Geographical segmentation
• Rapid diagnostics market in Americas
• Rapid diagnostics market in EMEA
• Rapid diagnostics market in APAC
PART 09: Market drivers
• Growing demand for rapid and accurate testing
• Launch of innovative rapid diagnostic kits and devices
• Favorable regulatory and reimbursement policies
• Increase in incidence of chronic and infectious diseases
PART 10: Impact of drivers
PART 11: Market challenges
• Pricing pressures
• Issues with reliability and stability of rapid diagnostic kits
• Lack of trained professionals
PART 12: Impact of drivers and challenges
PART 13: Market trends
Use of digital platforms in rapid diagnostics
• Initiatives by non-profit entities and governments to increase awareness
• Adoption of rapid diagnostic kits in middle- and low-income countries
PART 14: Vendor landscape
• Competitive scenario
• Market share analysis 2015
• Abbott Diagnostics
• Alere
• Beckman Coulter
• Roche Diagnostics
• Siemens Healthcare
• Other prominent vendors
PART 15: Appendix
• List of abbreviations
PART 16: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Global rapid diagnostics market 2015-2020 ($ billions)
Exhibit 03: Five forces analysis
Exhibit 04: Global rapid diagnostics market by application
Exhibit 05: Global rapid diagnostics market by application 2015
Exhibit 06: Global rapid diagnostics market by application 2020
Exhibit 07: Global rapid diagnostics market by application 2015-2020
Exhibit 08: Global blood glucose rapid diagnostics market 2015-2020 ($ billions)
Exhibit 09: Global cardiometabolic rapid diagnostics market 2015-2020 ($ billions)
Exhibit 10: Segmentation of global cardiometabolic rapid diagnostics market by application
Exhibit 11: Segmentation of global cardiometabolic rapid diagnostics market by application 2015
Exhibit 12: Global blood gas rapid diagnostics market 2015-2020 ($ billions)
Exhibit 13: Global cardiac marker rapid diagnostics market 2015-2020 ($ millions)
Exhibit 14: Global HbA1c rapid diagnostics market 2015-2020 ($ millions)
Exhibit 15: Global lipids rapid diagnostics market 2015-2020 ($ millions)
Exhibit 16: Global infectious disease rapid diagnostics market 2015-2020 ($ billions)
Exhibit 17: Global infectious disease rapid diagnostics market by application
Exhibit 18: Segmentation of global infectious disease rapid diagnostics market by application 2015
Exhibit 19: Global infectious disease rapid diagnostics market by application 2014-2019
Exhibit 20: Global respiratory illnesses rapid diagnostic testing market 2015-2020 ($ millions)
Exhibit 21: Global hepatitis rapid diagnostics market 2015-2020 ($ millions)
Exhibit 22: Global HAI rapid diagnostics market 2015-2020 ($ millions)
Exhibit 23: Global tropical diseases rapid diagnostics market 2015-2020 ($ millions)
Exhibit 24: Global sexual health rapid diagnostics market 2015-2020 ($ millions)
Exhibit 25: Demographic statistics for HIV 2014
Exhibit 26: Global HIV rapid diagnostics market 2015-2020 ($ millions)
Exhibit 27: Global pregnancy and fertility rapid diagnostics market 2015-2020 ($ millions)
Exhibit 28: Global toxicology rapid diagnostics market 2015-2020 ($ millions)
Exhibit 29: Global fecal occult blood rapid diagnostics market 2015-2020 ($ millions)
Exhibit 30: Global coagulation rapid diagnostics market 2015-2020 ($ millions)
Exhibit 31: Segmentation of global rapid diagnostics market by product 2015
Exhibit 32: Segmentation of global rapid diagnostics market by geography 2015
Exhibit 33: Segmentation of global rapid diagnostics market by geography 2020
Exhibit 34: Segmentation of global rapid diagnostics market by geography 2015-2020
Exhibit 35: Rapid diagnostics market in Americas 2015-2020 ($ billions)
Exhibit 36: Rapid diagnostics market in EMEA 2015-2020 ($ billions)
Exhibit 37: Rapid diagnostics market in APAC 2015-2020 ($ billions)
Exhibit 38: Impact of drivers
Exhibit 39: Impact of drivers and challenges
Exhibit 40: Ranking of key vendors 2015
Exhibit 41: Product portfolio of vendors by application
Exhibit 42: Abbott Diagnostics: Key takeaways
Exhibit 43: Alere: Key takeaways
Exhibit 44: Beckman Coulter: Key takeaways
Exhibit 45: Roche Diagnostics: Key takeaways
Exhibit 46: Siemens Healthcare: Key takeaways
